This is what WHO say:
http://www.whocc.no/atc_ddd_index/?c...description=no
But to add to Nicola's comment, which I agree with, WHO also state the following about how this a comparison of the drug, not the effect on the patient:
Definition and introduction
The basic definition of the defined daily dose (DDD) is:
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults.
A DDD will only be assigned for drugs that already have an ATC code.
It should be emphasised that the defined daily dose is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Doses for individual patients and patient groups will often differ from the DDD and will necessarily have to be based on individual characteristics (e.g. age and weight) and pharmacokinetic considerations.
For the optimal use of drugs, it is important to recognise that genetic polymorphism due to ethnic differences can result in variations in pharmaco-kinetics of drugs. The DDD should reflect the global dosage irrespective of genetic variations of drug metabolism.
Drug consumption data presented in DDDs only give a rough estimate of consumption and not an exact picture of actual use. The DDD provide a fixed unit of measurement independent of price and dosage form (e.g. tablet strength) enabling the researcher to assess trends in drug consumption and to perform comparisons between population groups.